Proteome Sciences plc (LON:PRM – Get Free Report) fell below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of GBX 3.75 ($0.05) and traded at a low of GBX 2.96 ($0.04). Proteome Sciences shares were last traded at GBX 3.60 ($0.05) with a trading volume of 232,944 shares.
Proteome Sciences trading up 13.2%
The company has a 50-day moving average of GBX 3.66 and a 200-day moving average of GBX 3.75. The stock has a market cap of £10.63 million, a price-to-earnings ratio of -360.00 and a beta of -0.03.
About Proteome Sciences
(Get free report)
Proteome Sciences plc provides contract research services for the identification, validation and application of protein biomarkers in the US, UK, European Union and worldwide. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when phosphopeptide enrichment is not required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, which provides analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyses where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Read more
Get daily news and reviews for Proteome Sciences – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Proteome Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.
